UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047458
Receipt number R000054117
Scientific Title Risk factors for operative morbidity and mortality after esophagectomy for esophageal cancer
Date of disclosure of the study information 2022/04/11
Last modified on 2022/04/11 12:55:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of diabetes control status on anastomotic leakage after esophagectomy for esophageal cancer

Acronym

Impact of diabetes control status on anastomotic leakage after esophagectomy for esophageal cancer

Scientific Title

Risk factors for operative morbidity and mortality after esophagectomy for esophageal cancer

Scientific Title:Acronym

Risk factors for operative morbidity and mortality after esophagectomy for esophageal cancer

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to evaluate the impact of diabetes control status on anastomotic leakage after esophagectomy for esophageal cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

the occurrence of anastomotic leakage

Key secondary outcomes

surgical site infection, respiratory complications, cardiovascular complications, operative morbidity, operative mortality, and length of hospital stay after surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A two-center database (2011-2019) was retrospectively reviewed to identify patients with esophageal cancer who underwent esophagectomy.

Key exclusion criteria

Patients who underwent two-stage reconstruction or who were missing HbA1c values were excluded from the study.

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Daiko

Organization

National Cancer Center Hospital

Division name

Division of Esophageal Surgery

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

+81-3-3542-2511

Email

hdaiko@ncc.go.jp


Public contact

Name of contact person

1st name Junya
Middle name
Last name Oguma

Organization

National Cancer Center Hospital

Division name

Division of Esophageal Surgery

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

+81-3-3542-2511

Homepage URL

https://www.ncc.go.jp/jp/about/research_promotion/study/list/2020-303.pdf

Email

joguma@ncc.go.jp


Sponsor or person

Institute

National Cancer Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

International University of Health and Welfare School of Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethics Committee at National Cancer Center

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

Tel

+81-3-3542-2511

Email

irst@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2020-303

Org. issuing International ID_1

the Ethics Committee at National Cancer Center

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院(東京都)、国立がん研究センター東病院(千葉県)、国際医療福祉大学医学部(千葉県)


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 11 Day


Related information

URL releasing protocol

https://www.ncc.go.jp/jp/about/research_promotion/study/list/2020-303.pdf

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2154

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 11 Month 08 Day

Date of IRB

2020 Year 12 Month 08 Day

Anticipated trial start date

2021 Year 01 Month 08 Day

Last follow-up date

2022 Year 04 Month 11 Day

Date of closure to data entry

2022 Year 07 Month 11 Day

Date trial data considered complete

2022 Year 07 Month 11 Day

Date analysis concluded

2022 Year 07 Month 11 Day


Other

Other related information

This study aimed to evaluate the impact of diabetes control status on anastomotic leakage after esophagectomy for esophageal cancer.


Management information

Registered date

2022 Year 04 Month 11 Day

Last modified on

2022 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054117


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name